Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Citi
Baxter
Johnson and Johnson
Dow
Healthtrust
Fuji
AstraZeneca

Generated: July 22, 2018

DrugPatentWatch Database Preview

Technetium tc-99m exametazime kit - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for technetium tc-99m exametazime kit and what is the scope of technetium tc-99m exametazime kit freedom to operate?

Technetium tc-99m exametazime kit
is the generic ingredient in two branded drugs marketed by Ge Healthcare and Jubilant Draximage, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m exametazime kit. Three suppliers are listed for this compound.
Summary for technetium tc-99m exametazime kit
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 4
Suppliers / Packagers: 3
DailyMed Link:technetium tc-99m exametazime kit at DailyMed
Pharmacology for technetium tc-99m exametazime kit

US Patents and Regulatory Information for technetium tc-99m exametazime kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage DRAX EXAMETAZIME technetium tc-99m exametazime kit POWDER;INTRAVENOUS 208870-001 Aug 17, 2017 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for technetium tc-99m exametazime kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Baxter
Cerilliant
Dow
Julphar
Chinese Patent Office
Moodys
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.